Weill–Marchesani syndrome is a rare genetic disorder of connective tissue characterised by short stature, restricted articular movements, brachydactyly, cardiac abnormalities and eye anomalies including microspherophakia, ectopia lentis, increased corneal thickness, severe myopia and secondary glaucoma [
1,
2]. There are different mutations depending on the mode of inheritance. Autosomal dominant (AD) inheritance is caused by a heterozygous mutation within the fibrillin-1 gene (FBN1) [
3,
4]. Autosomal recessive (AR) cases can be caused by diverse mutations that include the genes for the ADAM metallopeptidase with thrombospondin type 1 motif 10 (ADAMTS10) and motif 17 (ADAMTS17), and for the latent transforming growth factor beta binding protein 2 (LTBP2). The prevalence is estimated at 1 in 100,000 in the population [
1,
5]. Most cases have been described by ophthalmologists due to the characteristic ocular signs and symptoms, even though on initial exams many can be misdiagnosed as high myopia and angle closure glaucoma [
1,
3] (
Figure 1 and
Figure 2).
Also known as microspherophakia–brachydactyly syndrome, Weill–Marchesani syndrome is a rare genetic disorder of the connective tissue. In a study published by Faivre et al., the autosomal dominant (AD) and recessive (AR) mode of inheritance accounted for 39% and 45% of the cases, whilst the remaining percentage were sporadic cases [
4,
5]. Our clinical findings are similar to those in the literature, with the exception of ectopia lentis, cataract, joint restriction (which was not evaluated by a specialist) and mental retardation. The characteristic features of Weill–Marchesani syndrome are as follows: microspherophakia (84%), myopia (94%), ectopia lentis (73%), glaucoma (80%), cataract (23%), short stature (98%), brachydactyly (98%), joint restriction (62%), cardiac abnormalities (24%) and mental retardation (13%) [
3,
4]. Recently, another ophthalmologic characteristic has been described, which is the abnormally increased corneal thickness that was also found in our case [
6,
7]. The increase in corneal thickness is associated with the activation of keratocytes in the anterior stroma, suggesting that corneal thickness increase can be a newly described feature of Weill–Marchesani syndrome [
8].
The morphological characteristics of Weill–Marchesani syndrome lead to multiple clinical manifestations and necessitate a specific surgical approach. The abnormal spherical shape of the lens (with an increased anterior curvature - and, therefore, increased refractive power) and the anterior displacement of the lens (causing a refractive shift) contribute to decreased visual acuity [
9,
10]. This can often be misdiagnosed as simple high myopia. The increased lens thickness along with the weak zonules allow the lens to move forward and cause pupillary block that leads to secondary closed-angle glaucoma [
9].
Besides Weill–Marchesani syndrome, mutations in the LTBP2 gene can also cause congenital glaucoma [
1], a rare disease with a high risk of blindness in children and which may also be accompanied by systemic pathologies [
11].
The extremely high IOP associated with this pathology leads to severe optic nerve damage if the diagnosis and treatment are not fast and efficient. Thus, lens extraction and intraocular lens implantation is the correct approach in secondary closed-angle glaucoma with pupillary block in microspherophakia. In our case, the absence of angle elements visible on indentation gonioscopy determined the decision to implant a filtration device (Shunt ExPress) in order to ensure effective IOP control. In the literature, laser iridotomy has been described as a treatment option, but disease progression is not necessarily managed by it, ultimately leading to lens extraction [
9]. Trabeculectomy without lens extraction was also described in the literature, and it was associated with an increased risk of malignant glaucoma, especially in the presence of a shallow anterior chamber [
9,
12], like in our patient.
Weill–Marchesani syndrome presents with a variety of clinical features of an ophthalmological, musculoskeletal, cardiac and psychiatric nature. This peculiarity implies the need for a multidisciplinary approach. The ophthalmologic symptoms are often the first reason for a patient consulting a specialist, and glaucoma is the most threatening of the ocular pathologies, with possible evolution into irreversible blindness; therefore, surgery becomes the key treatment. Our take-home message is that clinicians should have a high level of suspicion of Weill–Marchesani syndrome in cases such as this with high lenticular myopia, multiple lens anomalies and angle-closure glaucoma in young patients, all associated with several systemic manifestations.
Author Contributions
Conceptualization, V.C.; methodology, M.G.B. and M.C.M.; investigation, V.C. and B.M.U.; resources, V.C.; writing—original draft preparation, V.C., M.G.B. and C.D.; writing—review and editing, V.C., C.D. and M.C.M.; visualisation, B.M.U.; supervision, V.C. and C.D.; project administration, V.C. All authors have read and agreed to the published version of the manuscript.
Funding
This research received no external funding.
Institutional Review Board Statement
The manuscript contains a case presentation; the work does not describe a medical experiment, and therefore, the approval of the bioethics committee was not required.
Informed Consent Statement
Written informed consent was obtained from the patient to publish this paper.
Data Availability Statement
All relevant data have been presented in this manuscript, and further inquiries can be directed to the corresponding author.
Conflicts of Interest
The authors declare no conflicts of interest.
References
- Marzin, P.; Cormier-Daire, V.; Tsilou, E. Weill–Marchesani Syndrome. In Gene Reviews; Adam, M.P., Feldman, J., Mirzaa, G.M., Pagon, R.A., Wallace, S.E., Bean, L.J.H., Gripp, K.W., Amemiya, A., Eds.; University of Washington, Seattle: Seattle, WA, USA, 2020. [Google Scholar]
- Al Motawa, M.N.A.; Al Shehri, M.S.S.; Al Buali, M.J.; Al Agnam, A.A.M. Weill–Marchesani Syndrome, a Rare Presentation of Severe Short Stature with Review of the Literature. Am. J. Case Rep. 2021, 22, e930824. [Google Scholar] [CrossRef] [PubMed]
- Yang, G.-Y.; Huang, X.; Chen, B.-J.; Xu, Z.-P. Weill–Marchesani-like Syndrome Caused by an FBN1 Mutation with Low-Penetrance. Chin. Med. J. 2021, 134, 1359–1361. [Google Scholar] [CrossRef] [PubMed]
- Faivre, L.; Dollfus, H.; Lyonnet, S.; Alembik, Y.; Mégarbané, A.; Samples, J.; Gorlin, R.J.; Alswaid, A.; Feingold, J.; Le Merrer, M.; et al. Clinical Homogeneity and Genetic Heterogeneity in Weill–Marchesani Syndrome. Am. J. Med. Genet. A 2003, 123A, 204–207. [Google Scholar] [CrossRef] [PubMed]
- Miao, N.; Zhang, Y.; Liao, J.-Y.; Zhou, L.; He, J.-C.; Yang, R.-Q.; Liu, X.-Y.; Tang, L. Novel Homozygous Missense Variant in Weill–Marchesani Syndrome. Int. J. Ophthalmol. 2023, 16, 694–699. [Google Scholar] [CrossRef] [PubMed]
- Roszkowska, A.M.; Aragona, P. Corneal Microstructural Analysis in Weill–Marchesani Syndrome by In Vivo Confocal Microscopy. Open Ophthalmol. J. 2011, 5, 48. [Google Scholar] [CrossRef] [PubMed]
- Potop, V.; Coviltir, V.; Corbu, C.; Burcel, M.G.; Ionescu, C.I.; Dascalescu, D.M.C. Corneal Hysteresis, a Glaucoma Risk Factor Independent of the Intraocular Pressure. Rev. Roum. Sci. Techn.–Électrotechn. Énerg. 2019, 64, 297–300. [Google Scholar]
- Guo, H.; Wu, X.; Cai, K.; Qiao, Z. Weill–Marchesani Syndrome with Advanced Glaucoma and Corneal Endothelial Dysfunction: A Case Report and Literature Review. BMC Ophthalmol. 2015, 15, 3. [Google Scholar] [CrossRef] [PubMed]
- Taylor, J.N. Weill–Marchesani Syndrome Complicated by Secondary Glaucoma. Case Management with Surgical Lens Extraction. Aust. N. Z. J. Ophthalmol. 1996, 24, 275–278. [Google Scholar] [CrossRef] [PubMed]
- Jethani, J.; Mishra, A.; Shetty, S.; Vijayalakshmi, P. Weill–Marchesani Syndrome Associated with Retinitis Pigmentosa. Indian J. Ophthalmol. 2007, 55, 142–143. [Google Scholar] [CrossRef] [PubMed]
- Dragosloveanu, C.D.M.; Potop, V.; Coviltir, V.; Dinu, V.; Păsărică, M.; Ducan, I.L.; Maier, C.; Dragosloveanu, Ş. Prematurity—Risk Factor or Coincidence in Congenital Glaucoma? Medicina 2022, 58, 334. [Google Scholar] [CrossRef] [PubMed]
- Senthil, S.; Rao, H.L.; Hoang, N.T.Q.; Jonnadula, G.B.; Addepalli, U.K.; Mandal, A.K.; Garudadari, C.S. Glaucoma in Microspherophakia: Presenting Features and Treatment Outcomes. J. Glaucoma 2014, 23, 262–267. [Google Scholar] [CrossRef] [PubMed]
| Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).